Bulnexo 8 mg/2 mg sublingual tablets
Country: Bulgaria
Language: Bulgarian
Source: Изпълнителна агенция по лекарствата
Patient Information leaflet
(PIL)
18-04-2022
Summary of Product characteristics
(SPC)
18-04-2022
Dosage:
8 mg/2 mg sublingual tablets
